Althea Group Holdings Limited is a healthcare company specializing in the manufacture, distribution, and sale of cannabis-based medicines and recreational cannabis products. Established in 2016 and headquartered in Melbourne, Australia, Althea operates in markets including Australia, the United Kingdom, Canada, Germany, and Ireland. The company offers a broad portfolio encompassing medicinal products, recreational cannabis formulations, and value-added consumables such as beverages, edibles, concentrates, and topicals. In addition to product development, Althea provides education, access, and management services to support healthcare professionals and eligible patients navigating medicinal cannabis treatment pathways. Notably, the company runs a network of private medical cannabis clinics under the MyAccess Clinics brand, further reinforcing its commitment to patient access and clinical integration. Althea’s operations position it within the specialty and generic drug manufacturing segment, with its main revenue streams coming from the pharmaceutical product manufacturing industry—particularly focused on innovative cannabinoid therapies that address unmet needs in both healthcare and wellness sectors. Its ongoing expansion across international markets highlights Althea’s role as a key provider in the evolving global medicinal and recreational cannabis landscape.